Pharma & Biotech

Krystal Biotech has delivered a stunning quarterly report that significantly surpassed market projections, demonstrating both robust commercial execution and strategic...

All eyes are on BridgeBio Pharma as the biotechnology firm approaches a pivotal medical conference that could significantly influence its...

While numerous financial assets struggle to maintain momentum, Hercules Capital continues to post exceptional results. This specialized lender to technology...

While Dynavax shares opened today's session down 1.3% at $10.26, institutional investors continue demonstrating strong confidence in the biotechnology firm....

PDS Biotechnology Corp (PDSB) is approaching a week of significant developments, with two major catalysts on the horizon. The clinical-stage...

Illumina has delivered a stunning quarterly performance that has reignited investor confidence in the genomics sector. The sequencing technology company,...

Sysmex Corporation finds itself navigating turbulent market conditions as its stock value continues to deteriorate. Despite receiving an unexpected analyst...

Natera Inc. finds itself at a pivotal moment as it prepares to release third-quarter 2025 financial results after market close...

Kura Oncology faces a defining period with two significant catalysts on the immediate horizon. The biotechnology firm prepares to disclose...

Eli Lilly has delivered a stunning quarterly performance that shattered market expectations, driven by two revolutionary medications transforming diabetes and...